128 related articles for article (PubMed ID: 24222129)
1. Targeting biliverdin reductase overcomes multidrug resistance in leukemia HL60 cells.
Kim SS; Seong S; Lim SH; Kim SY
Anticancer Res; 2013 Nov; 33(11):4913-9. PubMed ID: 24222129
[TBL] [Abstract][Full Text] [Related]
2. The ability of selected pyridinium salts to increase the cytotoxic activity of vincristine but not doxorubicin towards sensitive and multidrug resistant promyelocytic leukaemia HL60 cells.
Maruszewska A; Kostrzewa-Nowak D; Adamus J; Czupryńska K; Maryniak D; Gebicki J; Tarasiuk J
J Pharm Pharmacol; 2008 May; 60(5):647-53. PubMed ID: 18416942
[TBL] [Abstract][Full Text] [Related]
3. Biliverdin reductase plays a crucial role in hypoxia-induced chemoresistance in human glioblastoma.
Kim SS; Seong S; Lim SH; Kim SY
Biochem Biophys Res Commun; 2013 Nov; 440(4):658-63. PubMed ID: 24113378
[TBL] [Abstract][Full Text] [Related]
4. B4GALT1 gene knockdown inhibits the hedgehog pathway and reverses multidrug resistance in the human leukemia K562/adriamycin-resistant cell line.
Zhou H; Zhang Z; Liu C; Jin C; Zhang J; Miao X; Jia L
IUBMB Life; 2012 Nov; 64(11):889-900. PubMed ID: 23024026
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of survivin via activation of ERK1/2, Akt, and NF-κB plays a central role in vincristine resistance in multiple myeloma cells.
Tsubaki M; Takeda T; Ogawa N; Sakamoto K; Shimaoka H; Fujita A; Itoh T; Imano M; Ishizaka T; Satou T; Nishida S
Leuk Res; 2015 Apr; 39(4):445-52. PubMed ID: 25726084
[TBL] [Abstract][Full Text] [Related]
7. Redox active copper chelate overcomes multidrug resistance in T-lymphoblastic leukemia cell by triggering apoptosis.
Ganguly A; Basu S; Banerjee K; Chakraborty P; Sarkar A; Chatterjee M; Chaudhuri SK
Mol Biosyst; 2011 May; 7(5):1701-12. PubMed ID: 21409205
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of harringtonine-resistant human leukemia HL60 cell.
He QY; Zhou WD; Ji L; Zhang HQ; He NG; Xue SB
Zhongguo Yao Li Xue Bao; 1996 Sep; 17(5):463-7. PubMed ID: 9863176
[TBL] [Abstract][Full Text] [Related]
9. CIAPIN1 confers multidrug resistance through up-regulation of MDR-1 and Bcl-L in LoVo/Adr cells and is independent of p53.
Zhang YF; Li XH; Shi YQ; Wu YY; Li N; He Q; Ji Q; Wang RQ; Yang SM; Fang DC
Oncol Rep; 2011 Apr; 25(4):1091-8. PubMed ID: 21240465
[TBL] [Abstract][Full Text] [Related]
10. Antimultidrug-resistant effect and mechanism of a novel CA-4 analogue MZ3 on leukemia cells.
Xu D; Fang L; Zhu Q; Hu Y; He Q; Yang B
Pharmazie; 2008 Jul; 63(7):528-33. PubMed ID: 18717489
[TBL] [Abstract][Full Text] [Related]
11. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of nucleophosmin by RNA interference reverses multidrug resistance in resistant leukemic HL-60 cells.
Lin M; Hu J; Liu T; Li J; Chen B; Chen X
Immunobiology; 2013 Sep; 218(9):1147-54. PubMed ID: 23669237
[TBL] [Abstract][Full Text] [Related]
13. Reversal effect of Raf-1/Mdr-1 siRNAs co-transfection on multidrug resistance in KBv200 cell line.
Dong Y; Shao S; Hu J; Yang P
Oral Oncol; 2009 Nov; 45(11):991-7. PubMed ID: 19631573
[TBL] [Abstract][Full Text] [Related]
14. Bioreductive activation of mitoxantrone by NADPH cytochrome P450 reductase does not change its apoptotic stimuli properties in regard to sensitive and multidrug resistant leukaemia HL60 cells.
Kostrzewa-Nowak D; Tarasiuk J
Eur J Pharmacol; 2013 Dec; 721(1-3):141-50. PubMed ID: 24076328
[TBL] [Abstract][Full Text] [Related]
15. Transport mechanism of anthracycline derivatives in human leukemia cell lines: uptake and efflux of pirarubicin in HL60 and pirarubicin-resistant HL60 cells.
Nagasawa K; Natazuka T; Chihara K; Kitazawa F; Tsumura A; Takara K; Nomiyama M; Ohnishi N; Yokoyama T
Cancer Chemother Pharmacol; 1996; 37(4):297-304. PubMed ID: 8548874
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial DNA depletion promotes impaired oxidative status and adaptive resistance to apoptosis in T47D breast cancer cells.
Yu M; Shi Y; Wei X; Yang Y; Zang F; Niu R
Eur J Cancer Prev; 2009 Nov; 18(6):445-57. PubMed ID: 19609211
[TBL] [Abstract][Full Text] [Related]
17. Complete reversal by thaliblastine of 490-fold adriamycin resistance in multidrug-resistant (MDR) human breast cancer cells. Evidence that multiple biochemical changes in MDR cells need not correspond to multiple functional determinants for drug resistance.
Chen G; Waxman DJ
J Pharmacol Exp Ther; 1995 Sep; 274(3):1271-7. PubMed ID: 7562498
[TBL] [Abstract][Full Text] [Related]
18. Combined Fourier transform infrared and Raman spectroscopic approach for identification of multidrug resistance phenotype in cancer cell lines.
Krishna CM; Kegelaer G; Adt I; Rubin S; Kartha VB; Manfait M; Sockalingum GD
Biopolymers; 2006 Aug; 82(5):462-70. PubMed ID: 16493658
[TBL] [Abstract][Full Text] [Related]
19. miR-138 might reverse multidrug resistance of leukemia cells.
Zhao X; Yang L; Hu J; Ruan J
Leuk Res; 2010 Aug; 34(8):1078-82. PubMed ID: 19896708
[TBL] [Abstract][Full Text] [Related]
20. Ligustrazine derivate DLJ14 reduces multidrug resistance of K562/A02 cells by modulating GSTπ activity.
Song YN; Guo XL; Zheng BB; Liu XY; Dong X; Yu LG; Cheng YN
Toxicol In Vitro; 2011 Jun; 25(4):937-43. PubMed ID: 21402141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]